Related Experiment Videos
ICAT-based comparative proteomic analysis of non-replicating persistent Mycobacterium tuberculosis.
Sang Hyun Cho1, David Goodlett, Scott Franzblau
1Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 S. Wood St, Chicago, IL 60612, USA. jkcn01@uic.edu <jkcn01@uic.edu>
Tuberculosis (Edinburgh, Scotland)
|December 27, 2005
Summary
Mycobacterium tuberculosis enters a non-replicating persistent (NRP) state, crucial for latent infections. Protein expression significantly changes during early and late NRP stages, particularly in metabolism, impacting treatment strategies.
Area of Science:
- Microbiology
- Proteomics
- Tuberculosis Research
Background:
- The non-replicating persistence (NRP) phenotype of Mycobacterium tuberculosis (NRP-TB) is implicated in latent tuberculosis infections and prolonged treatment durations.
- Understanding protein expression changes during NRP is critical for developing effective therapeutic strategies against tuberculosis.
Purpose of the Study:
- To investigate the proteomic landscape of Mycobacterium tuberculosis during different stages of non-replicating persistence (NRP).
- To identify differentially expressed proteins and their functional roles in early (NRP-1) and later (NRP-2) stages of NRP.
Main Methods:
- Utilized isotope-coded affinity tag-based proteomic analysis to quantify relative protein expression in Mycobacterium tuberculosis.
- Compared protein expression profiles between log phase and two distinct NRP stages (NRP-1 and NRP-2) under controlled oxygen-depleted conditions.
- Monitored the expression of the alpha-crystallin homolog protein (acr) to confirm entry into the NRP state.
Main Results:
- Significant alterations in protein expression were observed between log phase and NRP stages: 6.5% and 20.4% of proteins were upregulated in NRP-1 and NRP-2, respectively.
- Conversely, 20.3% and 13.4% of proteins were downregulated in NRP-1 and NRP-2, respectively.
- Proteins involved in small molecule metabolism were highly represented (42.1%/39.8% upregulated, 41.2%/45.2% downregulated in NRP-1/NRP-2). Degradation and energy metabolism were prominent in NRP-1 and NRP-2, respectively.
Conclusions:
- Mycobacterium tuberculosis exhibits distinct proteomic profiles during early and later stages of non-replicating persistence.
- Metabolic pathways, including degradation and energy metabolism, undergo significant modulation during the NRP phenotype.
- These findings provide insights into the adaptive strategies of M. tuberculosis during persistent infection, potentially informing new treatment approaches.